{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:20:16Z","timestamp":1768447216696,"version":"3.49.0"},"publisher-location":"Cham","reference-count":202,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319571911","type":"print"},{"value":"9783319571935","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-57193-5_13","type":"book-chapter","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T09:03:24Z","timestamp":1499072604000},"page":"335-364","source":"Crossref","is-referenced-by-count":10,"title":["Prion Diseases"],"prefix":"10.1007","author":[{"given":"Benjamin C.","family":"Whitechurch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.","family":"Welton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"issue":"23","key":"13_CR1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95(23):13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"13_CR2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00005072-197611000-00001","volume":"35","author":"CL Masters","year":"1976","unstructured":"Masters CL, Kakulas BA et al (1976) Preclinical lesions and their progression in the experimental spongiform encephalopathies (kuru and Creutzfeldt-Jakob disease) in primates. J Neuropathol Exp Neurol 35(6):593\u2013605","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"13_CR3","doi-asserted-by":"crossref","first-page":"19P","DOI":"10.1042\/bj1140019P","volume":"114","author":"EJ Field","year":"1969","unstructured":"Field EJ, Peat A (1969) Structural changes in scrapieaffected brain. Biochem J 114(2):19P\u201320P","journal-title":"Biochem J"},{"issue":"8","key":"13_CR4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.37.8.1271","volume":"37","author":"SJ DeArmond","year":"1987","unstructured":"DeArmond SJ, Mobley WC et al (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37(8):1271\u20131280","journal-title":"Neurology"},{"issue":"7568","key":"13_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane Z, Mead S et al (2015) Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 525(7568):247\u2013250","journal-title":"Nature"},{"issue":"29","key":"13_CR6","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M et al (2014) Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 111(29):10732\u201310737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6109","key":"13_CR7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V et al (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949\u2013953","journal-title":"Science"},{"issue":"5","key":"13_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0736-4679(97)00152-2","volume":"15","author":"G Sternbach","year":"1997","unstructured":"Sternbach G, Dibble CL et al (1997) From Creutzfeldt-Jakob disease to the mad cow epidemic. J Emerg Med 15(5):701\u2013705","journal-title":"J Emerg Med"},{"issue":"5","key":"13_CR9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P Brown","year":"1994","unstructured":"Brown P, Gibbs CJ Jr et al (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35(5):513\u2013529","journal-title":"Ann Neurol"},{"issue":"12","key":"13_CR10","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/jnnp-2012-304820","volume":"84","author":"GM Klug","year":"2013","unstructured":"Klug GM, Wand H et al (2013) Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry 84(12):1372\u20131377","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.410200507","volume":"20","author":"P Brown","year":"1986","unstructured":"Brown P, Cathala F et al (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20(5):597\u2013602","journal-title":"Ann Neurol"},{"issue":"2","key":"13_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kovacs","year":"2005","unstructured":"Kovacs GG, Puopolo M et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118(2):166\u2013174","journal-title":"Hum Genet"},{"issue":"3","key":"13_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","volume":"2","author":"P Montagna","year":"2003","unstructured":"Montagna P, Gambetti P et al (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2(3):167\u2013176","journal-title":"Lancet Neurol"},{"issue":"1","key":"13_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.1995.tb00578.x","volume":"5","author":"B Ghetti","year":"1995","unstructured":"Ghetti B, Dlouhy SR et al (1995) Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 5(1):61\u201375","journal-title":"Brain Pathol"},{"issue":"20","key":"13_CR15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM195711142572005","volume":"257","author":"DC Gajdusek","year":"1957","unstructured":"Gajdusek DC, Zigas V (1957) Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N Engl J Med 257(20):974\u2013978","journal-title":"N Engl J Med"},{"issue":"1510","key":"13_CR16","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1098\/rstb.2008.0071","volume":"363","author":"MP Alpers","year":"2008","unstructured":"Alpers MP (2008) Review. The epidemiology of kuru: monitoring the epidemic from its peak to its end. Philos Trans R Soc Lond Ser B Biol Sci 363(1510):3707\u20133713","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"6650","key":"13_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce ME, Will RG et al (1997) Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent. Nature 389(6650):498\u2013501","journal-title":"Nature"},{"issue":"6650","key":"13_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill AF, Desbruslais M et al (1997) The same prion strain causes vCJD and BSE. Nature 389(6650):448\u2013450. 526","journal-title":"Nature"},{"issue":"4","key":"13_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vox.12371","volume":"110","author":"PJ Urwin","year":"2015","unstructured":"Urwin PJ, Mackenzie JM et al (2015) Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study. Vox Sang 110(4):310\u2013316","journal-title":"Vox Sang"},{"key":"13_CR20","unstructured":"The National CJD Research & Surveillance Unit Western General Hospital E, EH4 2XU (2014) 23rd annual report 2014. Creutzfeldt-Jakob Disease Surveillance in the UK"},{"issue":"5","key":"13_CR21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1537-2995.2004.03307.x","volume":"44","author":"EL Murphy","year":"2004","unstructured":"Murphy EL, David Connor J et\u00a0al (2004) Estimating blood donor loss due to the variant CJD travel deferral. Transfusion 44(5):645\u2013650","journal-title":"Transfusion"},{"issue":"4","key":"13_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4161\/pri.29237","volume":"8","author":"AB Diack","year":"2014","unstructured":"Diack AB, Head MW et al (2014) Variant CJD. 18 years of research and surveillance. Prion 8(4):286\u2013295","journal-title":"Prion"},{"issue":"6","key":"13_CR23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18(6):901\u2013907","journal-title":"Emerg Infect Dis"},{"issue":"Pt 10","key":"13_CR24","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1099\/vir.0.82961-0","volume":"88","author":"VA Lawson","year":"2007","unstructured":"Lawson VA, Stewart JD et al (2007) Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. J Gen Virol 88(Pt 10):2905\u20132914","journal-title":"J Gen Virol"},{"issue":"2","key":"13_CR25","first-page":"49","volume":"10","author":"PJ Plummer","year":"1946","unstructured":"Plummer PJ (1946) Scrapie-A disease of sheep: a review of the literature. Can J Comp Med Vet Sci 10(2):49\u201354","journal-title":"Can J Comp Med Vet Sci"},{"issue":"18","key":"13_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/vr.121.18.419","volume":"121","author":"GA Wells","year":"1987","unstructured":"Wells GA, Scott AC et al (1987) A novel progressive spongiform encephalopathy in cattle. Vet Rec 121(18):419\u2013420","journal-title":"Vet Rec"},{"issue":"25","key":"13_CR27","first-page":"638","volume":"123","author":"JW Wilesmith","year":"1988","unstructured":"Wilesmith JW, Wells GA et al (1988) Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 123(25):638\u2013644","journal-title":"Vet Rec"},{"issue":"18","key":"13_CR28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/vr.123.18.472","volume":"123","author":"H Fraser","year":"1988","unstructured":"Fraser H, McConnell I et al (1988) Transmission of bovine spongiform encephalopathy to mice. Vet Rec 123(18):472","journal-title":"Vet Rec"},{"issue":"3","key":"13_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0034-5288(92)90032-W","volume":"52","author":"JW Wilesmith","year":"1992","unstructured":"Wilesmith JW, Ryan JB et al (1992) Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates. Res Vet Sci 52(3):325\u2013331","journal-title":"Res Vet Sci"},{"issue":"1","key":"13_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2460\/javma.234.1.59","volume":"234","author":"JL Harman","year":"2009","unstructured":"Harman JL, Silva CJ (2009) Bovine spongiform encephalopathy. J Am Vet Med Assoc 234(1):59\u201372","journal-title":"J Am Vet Med Assoc"},{"key":"13_CR31","unstructured":"World Organisation for Animal Health:\u00a0Number of cases of bovine spongiform encephalopathy (BSE) reported in the United Kingdom.\u00a0 http:\/\/www.oie.int\/animal-health-in-the-world\/bse-specific-data\/number-of-cases-in-the-united-kingdom\/#Royaume-Uni (2016). Accessed\u00a028th April 2016"},{"issue":"2","key":"13_CR32","first-page":"195","volume":"47","author":"PP Liberski","year":"2009","unstructured":"Liberski PP, Sikorska B et al (2009) Transmissible mink encephalopathy\u2014review of the etiology of a rare prion disease. Folia Neuropathol 47(2):195\u2013204","journal-title":"Folia Neuropathol"},{"issue":"7","key":"13_CR33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/vr.153.7.202","volume":"153","author":"SL Benestad","year":"2003","unstructured":"Benestad SL, Sarradin P et al (2003) Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec 153(7):202\u2013208","journal-title":"Vet Rec"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-94-007-5416-4_18","volume":"65","author":"O Windl","year":"2012","unstructured":"Windl O, Dawson M (2012) Animal prion diseases. Subcell Biochem 65:497\u2013516","journal-title":"Subcell Biochem"},{"issue":"1","key":"13_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7589\/0090-3558-16.1.89","volume":"16","author":"ES Williams","year":"1980","unstructured":"Williams ES, Young S (1980) Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 16(1):89\u201398","journal-title":"J Wildl Dis"},{"issue":"1","key":"13_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7589\/0090-3558-33.1.1","volume":"33","author":"TR Spraker","year":"1997","unstructured":"Spraker TR, Miller MW et al (1997) Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) and Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado. J Wildl Dis 33(1):1\u20136","journal-title":"J Wildl Dis"},{"issue":"4","key":"13_CR37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7589\/0090-3558-36.4.676","volume":"36","author":"MW Miller","year":"2000","unstructured":"Miller MW, Williams ES et al (2000) Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming. J Wildl Dis 36(4):676\u2013690","journal-title":"J Wildl Dis"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-animal-022114-111001","volume":"3","author":"NJ Haley","year":"2015","unstructured":"Haley NJ, Hoover EA (2015) Chronic wasting disease of cervids: current knowledge and future perspectives. Annu Rev Anim Biosci 3:305\u2013325","journal-title":"Annu Rev Anim Biosci"},{"issue":"8","key":"13_CR39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.celrep.2015.04.036","volume":"11","author":"S Pritzkow","year":"2015","unstructured":"Pritzkow S, Morales R et al (2015) Grass plants bind, retain, uptake, and transport infectious prions. Cell Rep 11(8):1168\u20131175","journal-title":"Cell Rep"},{"issue":"5796","key":"13_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1132661","volume":"314","author":"CK Mathiason","year":"2006","unstructured":"Mathiason CK, Powers JG et al (2006) Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314(5796):133\u2013136","journal-title":"Science"},{"issue":"6","key":"13_CR41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3201\/eid1006.040010","volume":"10","author":"MW Miller","year":"2004","unstructured":"Miller MW, Williams ES et al (2004) Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10(6):1003\u20131006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"13_CR42","first-page":"169","volume":"51","author":"A Balachandran","year":"2010","unstructured":"Balachandran A, Harrington NP et al (2010) Experimental oral transmission of chronic wasting disease to red deer (Cervus elaphus elaphus): early detection and late stage distribution of protease-resistant prion protein. Can Vet J 51(2):169\u2013178","journal-title":"Can Vet J"},{"issue":"5","key":"13_CR43","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1354\/vp.39-5-546","volume":"39","author":"TR Spraker","year":"2002","unstructured":"Spraker TR, Zink RR et al (2002) Distribution of protease-resistant prion protein and spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease. Vet Pathol 39(5):546\u2013556","journal-title":"Vet Pathol"},{"issue":"Pt 11","key":"13_CR44","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1099\/vir.0.81777-0","volume":"87","author":"JE Jewell","year":"2006","unstructured":"Jewell JE, Brown J et\u00a0al (2006) Prion protein in cardiac muscle of elk (Cervus elaphus nelsoni) and white-tailed deer (Odocoileus virginianus) infected with chronic wasting disease. J Gen Virol 87(Pt 11):3443\u20133450","journal-title":"J Gen Virol"},{"issue":"5764","key":"13_CR45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/science.1122864","volume":"311","author":"RC Angers","year":"2006","unstructured":"Angers RC, Browning SR et al (2006) Prions in skeletal muscles of deer with chronic wasting disease. Science 311(5764):1117","journal-title":"Science"},{"issue":"6","key":"13_CR46","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3201\/eid1006.031082","volume":"10","author":"ED Belay","year":"2004","unstructured":"Belay ED, Maddox RA et al (2004) Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 10(6):977\u2013984","journal-title":"Emerg Infect Dis"},{"issue":"47","key":"13_CR47","first-page":"516","volume":"58","author":"WS Gordon","year":"1946","unstructured":"Gordon WS (1946) Advances in veterinary research. Vet Rec 58(47):516\u2013525","journal-title":"Vet Rec"},{"key":"13_CR48","first-page":"1058","volume":"208","author":"J Cuill\u00e9","year":"1939","unstructured":"Cuill\u00e9 J, Chelle PL (1939) Transmission experimentale de la tremblante a la chevre. Comptes rendus hebdomadaires des sciences de l\u2019Academie des Sciences 208:1058\u20131060","journal-title":"Comptes rendus hebdomadaires des sciences de l\u2019Academie des Sciences"},{"issue":"7191","key":"13_CR49","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(61)92008-6","volume":"1","author":"RL Chandler","year":"1961","unstructured":"Chandler RL (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1(7191):1378\u20131379","journal-title":"Lancet"},{"issue":"5025","key":"13_CR50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/209794a0","volume":"209","author":"DC Gajdusek","year":"1966","unstructured":"Gajdusek DC, Gibbs CJ et al (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209(5025):794\u2013796","journal-title":"Nature"},{"issue":"Pt 12","key":"13_CR51","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1099\/vir.0.82011-0","volume":"87","author":"G Georgsson","year":"2006","unstructured":"Georgsson G, Sigurdarson S et al (2006) Infectious agent of sheep scrapie may persist in the environment for at least 16 years. J Gen Virol 87(Pt 12):3737\u20133740","journal-title":"J Gen Virol"},{"issue":"13","key":"13_CR52","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1134\/S0006297911130013","volume":"76","author":"EG Afanasieva","year":"2011","unstructured":"Afanasieva EG, Kushnirov VV et al (2011) Interspecies transmission of prions. Biochemistry (Mosc) 76(13):1375\u20131384","journal-title":"Biochemistry (Mosc)"},{"issue":"3","key":"13_CR53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-291X(66)90478-5","volume":"22","author":"T Alper","year":"1966","unstructured":"Alper T, Haig DA et al (1966) The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22(3):278\u2013284","journal-title":"Biochem Biophys Res Commun"},{"issue":"90","key":"13_CR54","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/214764a0","volume":"214","author":"T Alper","year":"1967","unstructured":"Alper T, Cramp WA et al (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214(90):764\u2013766","journal-title":"Nature"},{"issue":"21","key":"13_CR55","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/bi00562a028","volume":"19","author":"SB Prusiner","year":"1980","unstructured":"Prusiner SB, Groth DF et al (1980) Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19(21):4883\u20134891","journal-title":"Biochemistry"},{"issue":"1","key":"13_CR56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/vr.80.1.2","volume":"80","author":"IH Pattison","year":"1967","unstructured":"Pattison IH, Jones KM (1967) The possible nature of the transmissible agent of scrapie. Vet Rec 80(1):2\u20139","journal-title":"Vet Rec"},{"issue":"4542","key":"13_CR57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542):136\u2013144","journal-title":"Science"},{"issue":"6017","key":"13_CR58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/315331a0","volume":"315","author":"B Chesebro","year":"1985","unstructured":"Chesebro B, Race R et al (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315(6017):331\u2013333","journal-title":"Nature"},{"issue":"2","key":"13_CR59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","volume":"51","author":"N Stahl","year":"1987","unstructured":"Stahl N, Borchelt DR et al (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51(2):229\u2013240","journal-title":"Cell"},{"issue":"1","key":"13_CR60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.42.1.149","volume":"42","author":"PE Bendheim","year":"1992","unstructured":"Bendheim PE, Brown HR et al (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42(1):149\u2013156","journal-title":"Neurology"},{"issue":"5","key":"13_CR61","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1006\/jmbi.1999.2831","volume":"289","author":"F Wopfner","year":"1999","unstructured":"Wopfner F, Weidenhofer G et al (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 289(5):1163\u20131178","journal-title":"J Mol Biol"},{"issue":"11","key":"13_CR62","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/v4113109","volume":"4","author":"S Yusa","year":"2012","unstructured":"Yusa S, Oliveira-Martins JB et al (2012) Cellular prion protein: from physiology to pathology. Virus 4(11):3109\u20133131","journal-title":"Virus"},{"issue":"15","key":"13_CR63","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1021\/bi982330q","volume":"38","author":"E Stimson","year":"1999","unstructured":"Stimson E, Hope J et\u00a0al (1999) Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography\/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38(15):4885\u20134895","journal-title":"Biochemistry"},{"issue":"1","key":"13_CR64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.97.1.145","volume":"97","author":"R Zahn","year":"2000","unstructured":"Zahn R, Liu A et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 97(1):145\u2013150","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6661","key":"13_CR65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/37733","volume":"390","author":"DR Brown","year":"1997","unstructured":"Brown DR, Qin K et al (1997) The cellular prion protein binds copper in vivo. Nature 390(6661):684\u2013687","journal-title":"Nature"},{"issue":"4","key":"13_CR66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/jmbi.1994.0030","volume":"245","author":"HM Schatzl","year":"1995","unstructured":"Schatzl HM, Da Costa M et al (1995) Prion protein gene variation among primates. J Mol Biol 245(4):362\u2013374","journal-title":"J Mol Biol"},{"issue":"12","key":"13_CR67","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/JVI.65.12.6597-6603.1991","volume":"65","author":"B Caughey","year":"1991","unstructured":"Caughey B, Raymond GJ et al (1991) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65(12):6597\u20136603","journal-title":"J Virol"},{"issue":"32","key":"13_CR68","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","volume":"270","author":"SG Chen","year":"1995","unstructured":"Chen SG, Teplow DB et al (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270(32):19173\u201319180","journal-title":"J Biol Chem"},{"issue":"3","key":"13_CR69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","volume":"73","author":"V Lewis","year":"2016","unstructured":"Lewis V, Johanssen VA et al (2016) Prion protein \u201cgamma-cleavage\u201d: characterizing a novel endoproteolytic processing event. Cell Mol Life Sci 73(3):667\u2013683","journal-title":"Cell Mol Life Sci"},{"key":"13_CR70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-6-36","volume":"6","author":"HC Altmeppen","year":"2011","unstructured":"Altmeppen HC, Prox J et\u00a0al (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6:36","journal-title":"Mol Neurodegener"},{"issue":"2","key":"13_CR71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mcn.2008.10.012","volume":"40","author":"AR Walmsley","year":"2009","unstructured":"Walmsley AR, Watt NT et al (2009) Alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 40(2):242\u2013248","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"13_CR72","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1074\/jbc.M007243200","volume":"276","author":"HE McMahon","year":"2001","unstructured":"McMahon HE, Mange A et al (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 276(3):2286\u20132291","journal-title":"J Biol Chem"},{"issue":"Pt 5","key":"13_CR73","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1042\/BST0331123","volume":"33","author":"NT Watt","year":"2005","unstructured":"Watt NT, Hooper NM (2005) Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress. Biochem Soc Trans 33(Pt 5):1123\u20131125","journal-title":"Biochem Soc Trans"},{"issue":"Pt 10","key":"13_CR74","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1242\/jcs.043604","volume":"122","author":"CL Haigh","year":"2009","unstructured":"Haigh CL, Drew SC et al (2009) Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection response. J Cell Sci 122(Pt 10):1518\u20131528","journal-title":"J Cell Sci"},{"issue":"8","key":"13_CR75","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00018-014-1777-y","volume":"72","author":"CL Haigh","year":"2015","unstructured":"Haigh CL, McGlade AR et al (2015) MEK1 transduces the prion protein N2 fragment antioxidant effects. Cell Mol Life Sci 72(8):1613\u20131629","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"13_CR76","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/NEN.0b013e3181b96981","volume":"68","author":"V Lewis","year":"2009","unstructured":"Lewis V, Hill AF et al (2009) Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. J Neuropathol Exp Neurol 68(10):1125\u20131135","journal-title":"J Neuropathol Exp Neurol"},{"issue":"51","key":"13_CR77","doi-asserted-by":"crossref","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","volume":"286","author":"L Westergard","year":"2011","unstructured":"Westergard L, Turnbaugh JA et al (2011) A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem 286(51):44234\u201344242","journal-title":"J Biol Chem"},{"issue":"51","key":"13_CR78","doi-asserted-by":"crossref","first-page":"35973","DOI":"10.1074\/jbc.M109.051086","volume":"284","author":"MV Guillot-Sestier","year":"2009","unstructured":"Guillot-Sestier MV, Sunyach C et al (2009) The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 284(51):35973\u201335986","journal-title":"J Biol Chem"},{"issue":"9","key":"13_CR79","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/cr.2009.86","volume":"19","author":"CL Haigh","year":"2009","unstructured":"Haigh CL, Lewis VA et al (2009) PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Res 19(9):1062\u20131078","journal-title":"Cell Res"},{"issue":"26","key":"13_CR80","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1523\/JNEUROSCI.1701-08.2008","volume":"28","author":"FA Caetano","year":"2008","unstructured":"Caetano FA, Lopes MH et al (2008) Endocytosis of prion protein is required for ERK1\/2 signaling induced by stress-inducible protein 1. J Neurosci 28(26):6691\u20136702","journal-title":"J Neurosci"},{"issue":"3","key":"13_CR81","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nn.2483","volume":"13","author":"J Bremer","year":"2010","unstructured":"Bremer J, Baumann F et al (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13(3):310\u2013318","journal-title":"Nat Neurosci"},{"key":"13_CR82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","volume":"31","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Baumann F et al (2008) The prion\u2019s elusive reason for being. Annu Rev Neurosci 31:439\u2013477","journal-title":"Annu Rev Neurosci"},{"key":"13_CR83","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fimmu.2015.00450","volume":"6","author":"MK Bakkebo","year":"2015","unstructured":"Bakkebo MK, Mouillet-Richard S et al (2015) The cellular prion protein: a player in immunological quiescence. Front Immunol 6:450","journal-title":"Front Immunol"},{"issue":"1","key":"13_CR84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/19336896.2015.1126038","volume":"10","author":"JA Rio Del","year":"2016","unstructured":"Del Rio JA, Gavin R (2016) Functions of the cellular prion protein, the end of Moore\u2019s law, and Ockham\u2019s razor theory. Prion 10(1):25\u201340","journal-title":"Prion"},{"issue":"7","key":"13_CR85","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H Bueler","year":"1993","unstructured":"Bueler H, Aguzzi A et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73(7):1339\u20131347","journal-title":"Cell"},{"issue":"4","key":"13_CR86","first-page":"331","volume":"3","author":"JC Manson","year":"1994","unstructured":"Manson JC, Clarke AR et al (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3(4):331\u2013340","journal-title":"Neurodegeneration"},{"issue":"8","key":"13_CR87","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.83.8.2310","volume":"83","author":"RK Meyer","year":"1986","unstructured":"Meyer RK, McKinley MP et al (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 83(8):2310\u20132314","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"13_CR88","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.90.23.10962","volume":"90","author":"KM Pan","year":"1993","unstructured":"Pan KM, Baldwin M et al (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90(23):10962\u201310966","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6489","key":"13_CR89","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/370471a0","volume":"370","author":"DA Kocisko","year":"1994","unstructured":"Kocisko DA, Come JH et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370(6489):471\u2013474","journal-title":"Nature"},{"issue":"Pt 1","key":"13_CR90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1099\/0022-1317-80-1-11","volume":"80","author":"AF Hill","year":"1999","unstructured":"Hill AF, Antoniou M et al (1999) Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 80(Pt 1):11\u201314","journal-title":"J Gen Virol"},{"issue":"6839","key":"13_CR91","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B et al (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411(6839):810\u2013813","journal-title":"Nature"},{"issue":"2","key":"13_CR92","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","volume":"121","author":"J Castilla","year":"2005","unstructured":"Castilla J, Saa P et al (2005) In vitro generation of infectious scrapie prions. Cell 121(2):195\u2013206","journal-title":"Cell"},{"issue":"5684","key":"13_CR93","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1100195","volume":"305","author":"G Legname","year":"2004","unstructured":"Legname G, Baskakov IV et al (2004) Synthetic mammalian prions. Science 305(5684):673\u2013676","journal-title":"Science"},{"issue":"1","key":"13_CR94","doi-asserted-by":"crossref","first-page":"e1000736","DOI":"10.1371\/journal.ppat.1000736","volume":"6","author":"DW Colby","year":"2010","unstructured":"Colby DW, Wain R et al (2010) Protease-sensitive synthetic prions. PLoS Pathog 6(1):e1000736","journal-title":"PLoS Pathog"},{"issue":"13","key":"13_CR95","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/sj.emboj.7600717","volume":"24","author":"KE Nazor","year":"2005","unstructured":"Nazor KE, Kuhn F et al (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 24(13):2472\u20132480","journal-title":"EMBO J"},{"issue":"11","key":"13_CR96","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/bi982328z","volume":"38","author":"R Cappai","year":"1999","unstructured":"Cappai R, Stewart L et al (1999) Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. Biochemistry 38(11):3280\u20133284","journal-title":"Biochemistry"},{"issue":"4987","key":"13_CR97","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.1980379","volume":"250","author":"KK Hsiao","year":"1990","unstructured":"Hsiao KK, Scott M et al (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250(4987):1587\u20131590","journal-title":"Science"},{"issue":"23","key":"13_CR98","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1093\/emboj\/18.23.6855","volume":"18","author":"JC Manson","year":"1999","unstructured":"Manson JC, Jamieson E et al (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18(23):6855\u20136864","journal-title":"EMBO J"},{"issue":"8","key":"13_CR99","doi-asserted-by":"crossref","first-page":"e12351","DOI":"10.1371\/journal.pone.0012351","volume":"5","author":"VA Lawson","year":"2010","unstructured":"Lawson VA, Lumicisi B et al (2010) Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein. PLoS One 5(8):e12351","journal-title":"PLoS One"},{"issue":"4","key":"13_CR100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.neuron.2009.07.026","volume":"63","author":"WS Jackson","year":"2009","unstructured":"Jackson WS, Borkowski AW et al (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63(4):438\u2013450","journal-title":"Neuron"},{"issue":"19","key":"13_CR101","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1074\/jbc.C110.113464","volume":"285","author":"JI Kim","year":"2010","unstructured":"Kim JI, Cali I et al (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285(19):14083\u201314087","journal-title":"J Biol Chem"},{"issue":"6","key":"13_CR102","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/abbs\/gmt027","volume":"45","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Xiao G (2013) Conformational conversion of prion protein in prion diseases. Acta Biochim Biophys Sin Shanghai 45(6):465\u2013476","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"22","key":"13_CR103","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1073\/pnas.1204498109","volume":"109","author":"NR Deleault","year":"2012","unstructured":"Deleault NR, Piro JR et al (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 109(22):8546\u20138551","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"13_CR104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4161\/pri.28939","volume":"8","author":"F Saleem","year":"2014","unstructured":"Saleem F, Bjorndahl TC et al (2014) Lipopolysaccharide induced conversion of recombinant prion protein. Prion 8(2):221\u2013232","journal-title":"Prion"},{"issue":"37","key":"13_CR105","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1021\/bi101146v","volume":"49","author":"F Wang","year":"2010","unstructured":"Wang F, Yin S et al (2010) Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 49(37):8169\u20138176","journal-title":"Biochemistry"},{"issue":"29","key":"13_CR106","doi-asserted-by":"crossref","first-page":"26873","DOI":"10.1074\/jbc.M503973200","volume":"280","author":"NR Deleault","year":"2005","unstructured":"Deleault NR, Geoghegan JC et al (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280(29):26873\u201326879","journal-title":"J Biol Chem"},{"issue":"28","key":"13_CR107","doi-asserted-by":"crossref","first-page":"E1938","DOI":"10.1073\/pnas.1206999109","volume":"109","author":"NR Deleault","year":"2012","unstructured":"Deleault NR, Walsh DJ et al (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 109(28):E1938\u2013E1946","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"13_CR108","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1128\/JVI.64.7.3265-3268.1990","volume":"64","author":"JM Aiken","year":"1990","unstructured":"Aiken JM, Williamson JL et al (1990) Presence of mitochondrial D-loop DNA in scrapie-infected brain preparations enriched for the prion protein. J Virol 64(7):3265\u20133268","journal-title":"J Virol"},{"issue":"6","key":"13_CR109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1515\/bchm.1998.379.6.655","volume":"379","author":"TR Klein","year":"1998","unstructured":"Klein TR, Kirsch D et al (1998) Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 379(6):655\u2013666","journal-title":"Biol Chem"},{"issue":"4","key":"13_CR110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00687367","volume":"77","author":"AD Snow","year":"1989","unstructured":"Snow AD, Kisilevsky R et al (1989) Sulfated glycosaminoglycans in amyloid plaques of prion diseases. Acta Neuropathol 77(4):337\u2013342","journal-title":"Acta Neuropathol"},{"issue":"5969","key":"13_CR111","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1183748","volume":"327","author":"F Wang","year":"2010","unstructured":"Wang F, Wang X et al (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327(5969):1132\u20131135","journal-title":"Science"},{"issue":"49","key":"13_CR112","doi-asserted-by":"crossref","first-page":"35878","DOI":"10.1074\/jbc.M704329200","volume":"282","author":"RM Barron","year":"2007","unstructured":"Barron RM, Campbell SL et al (2007) High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 282(49):35878\u201335886","journal-title":"J Biol Chem"},{"issue":"5","key":"13_CR113","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/JVI.02720-13","volume":"88","author":"BM Coleman","year":"2014","unstructured":"Coleman BM, Harrison CF et al (2014) Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. J Virol 88(5):2690\u20132703","journal-title":"J Virol"},{"key":"13_CR114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-7-18","volume":"7","author":"V Lewis","year":"2012","unstructured":"Lewis V, Haigh CL et al (2012) Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Mol Neurodegener 7:18","journal-title":"Mol Neurodegener"},{"issue":"6","key":"13_CR115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.21420","volume":"63","author":"P Gambetti","year":"2008","unstructured":"Gambetti P, Dong Z et al (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63(6):697\u2013708","journal-title":"Ann Neurol"},{"issue":"12","key":"13_CR116","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3201\/eid2012.140214","volume":"20","author":"AB Diack","year":"2014","unstructured":"Diack AB, Ritchie DL et al (2014) Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties. Emerg Infect Dis 20(12):1969\u20131979","journal-title":"Emerg Infect Dis"},{"issue":"6420","key":"13_CR117","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/362543a0","volume":"362","author":"G Forloni","year":"1993","unstructured":"Forloni G, Angeretti N et al (1993) Neurotoxicity of a prion protein fragment. Nature 362(6420):543\u2013546","journal-title":"Nature"},{"key":"13_CR118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2016.02.065","volume":"114","author":"P Salahuddin","year":"2016","unstructured":"Salahuddin P, Fatima MT et al (2016) Structure of amyloid oligomers and their mechanisms of toxicities: targeting amyloid oligomers using novel therapeutic approaches. Eur J Med Chem 114:41\u201358","journal-title":"Eur J Med Chem"},{"issue":"1\u20132","key":"13_CR119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2004.09.030","volume":"372","author":"J Weise","year":"2004","unstructured":"Weise J, Crome O et al (2004) Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 372(1\u20132):146\u2013150","journal-title":"Neurosci Lett"},{"issue":"1","key":"13_CR120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroscience.2005.06.095","volume":"136","author":"Y Sakurai-Yamashita","year":"2005","unstructured":"Sakurai-Yamashita Y, Sakaguchi S et al (2005) Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein. Neuroscience 136(1):281\u2013287","journal-title":"Neuroscience"},{"issue":"2","key":"13_CR121","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0092-8674(00)81572-X","volume":"93","author":"D Shmerling","year":"1998","unstructured":"Shmerling D, Hegyi I et al (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93(2):203\u2013214","journal-title":"Cell"},{"issue":"25","key":"13_CR122","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1073\/pnas.94.25.13452","volume":"94","author":"DG Donne","year":"1997","unstructured":"Donne DG, Viles JH et al (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A 94(25):13452\u201313457","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"13_CR123","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0014-5793(97)00920-4","volume":"413","author":"R Riek","year":"1997","unstructured":"Riek R, Hornemann S et al (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413(2):282\u2013288","journal-title":"FEBS Lett"},{"issue":"5663","key":"13_CR124","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1094273","volume":"303","author":"L Solforosi","year":"2004","unstructured":"Solforosi L, Criado JR et al (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303(5663):1514\u20131516","journal-title":"Science"},{"issue":"7465","key":"13_CR125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12402","volume":"501","author":"T Sonati","year":"2013","unstructured":"Sonati T, Reimann RR et al (2013) The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501(7465):102\u2013106","journal-title":"Nature"},{"issue":"2","key":"13_CR126","doi-asserted-by":"crossref","first-page":"e1004662","DOI":"10.1371\/journal.ppat.1004662","volume":"11","author":"US Herrmann","year":"2015","unstructured":"Herrmann US, Sonati T et al (2015) Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathog 11(2):e1004662","journal-title":"PLoS Pathog"},{"issue":"7233","key":"13_CR127","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA et al (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457(7233):1128\u20131132","journal-title":"Nature"},{"issue":"18","key":"13_CR128","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1523\/JNEUROSCI.3526-13.2014","volume":"34","author":"I Klyubin","year":"2014","unstructured":"Klyubin I, Nicoll AJ et al (2014) Peripheral administration of a humanized anti-PrP antibody blocks Alzheimer\u2019s disease Abeta synaptotoxicity. J Neurosci 34(18):6140\u20136145","journal-title":"J Neurosci"},{"issue":"5","key":"13_CR129","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","volume":"107","author":"C Balducci","year":"2010","unstructured":"Balducci C, Beeg M et al (2010) Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A 107(5):2295\u20132300","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"13_CR130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella AM, Farinelli M et al (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2(8):306\u2013314","journal-title":"EMBO Mol Med"},{"issue":"29","key":"13_CR131","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1523\/JNEUROSCI.1459-11.2011","volume":"31","author":"M Cisse","year":"2011","unstructured":"Cisse M, Sanchez PE et al (2011) Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 31(29):10427\u201310431","journal-title":"J Neurosci"},{"issue":"7308","key":"13_CR132","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/nature09217","volume":"466","author":"HW Kessels","year":"2010","unstructured":"Kessels HW, Nguyen LN et al (2010) The prion protein as a receptor for amyloid-beta. Nature 466(7308):E3\u2013E4. discussion E-5","journal-title":"Nature"},{"issue":"5352","key":"13_CR133","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.279.5352.827","volume":"279","author":"RS Hegde","year":"1998","unstructured":"Hegde RS, Mastrianni JA et al (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279(5352):827\u2013834","journal-title":"Science"},{"issue":"6763","key":"13_CR134","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/45574","volume":"402","author":"RS Hegde","year":"1999","unstructured":"Hegde RS, Tremblay P et al (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402(6763):822\u2013826","journal-title":"Nature"},{"issue":"24","key":"13_CR135","doi-asserted-by":"crossref","first-page":"21732","DOI":"10.1074\/jbc.M213247200","volume":"278","author":"B Drisaldi","year":"2003","unstructured":"Drisaldi B, Stewart RS et al (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278(24):21732\u201321743","journal-title":"J Biol Chem"},{"issue":"4","key":"13_CR136","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1091\/mbc.12.4.881","volume":"12","author":"RS Stewart","year":"2001","unstructured":"Stewart RS, Drisaldi B et al (2001) A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic reticulum. Mol Biol Cell 12(4):881\u2013889","journal-title":"Mol Biol Cell"},{"issue":"13","key":"13_CR137","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1523\/JNEUROSCI.0105-05.2005","volume":"25","author":"RS Stewart","year":"2005","unstructured":"Stewart RS, Piccardo P et al (2005) Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 25(13):3469\u20133477","journal-title":"J Neurosci"},{"issue":"23","key":"13_CR138","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1038\/sj.emboj.7600462","volume":"23","author":"NS Rane","year":"2004","unstructured":"Rane NS, Yonkovich JL et al (2004) Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J 23(23):4550\u20134559","journal-title":"EMBO J"},{"issue":"26","key":"13_CR139","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1073\/pnas.011578098","volume":"98","author":"J Ma","year":"2001","unstructured":"Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci U S A 98(26):14955\u201314960","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5599","key":"13_CR140","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1073619","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma J, Lindquist S (2002) Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298(5599):1785\u20131788","journal-title":"Science"},{"issue":"5599","key":"13_CR141","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1073725","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma J, Wollmann R et al (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298(5599):1781\u20131785","journal-title":"Science"},{"issue":"19","key":"13_CR142","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1093\/emboj\/20.19.5383","volume":"20","author":"Y Yedidia","year":"2001","unstructured":"Yedidia Y, Horonchik L et al (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 20(19):5383\u20135391","journal-title":"EMBO J"},{"issue":"20","key":"13_CR143","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1093\/emboj\/cdg537","volume":"22","author":"C Hetz","year":"2003","unstructured":"Hetz C, Russelakis-Carneiro M et al (2003) Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 22(20):5435\u20135445","journal-title":"EMBO J"},{"issue":"6","key":"13_CR144","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/35014014","volume":"2","author":"A Bertolotti","year":"2000","unstructured":"Bertolotti A, Zhang Y et al (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2(6):326\u2013332","journal-title":"Nat Cell Biol"},{"issue":"3","key":"13_CR145","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/MCB.25.3.921-932.2005","volume":"25","author":"J Shen","year":"2005","unstructured":"Shen J, Snapp EL et al (2005) Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Mol Cell Biol 25(3):921\u2013932","journal-title":"Mol Cell Biol"},{"issue":"3","key":"13_CR146","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2006.05.011","volume":"23","author":"E Ferreiro","year":"2006","unstructured":"Ferreiro E, Resende R et al (2006) An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 23(3):669\u2013678","journal-title":"Neurobiol Dis"},{"issue":"206","key":"13_CR147","doi-asserted-by":"crossref","first-page":"206ra138","DOI":"10.1126\/scitranslmed.3006767","volume":"5","author":"JA Moreno","year":"2013","unstructured":"Moreno JA, Halliday M et al (2013) Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 5(206):206ra138","journal-title":"Sci Transl Med"},{"issue":"4","key":"13_CR148","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H Budka","year":"1995","unstructured":"Budka H, Aguzzi A et al (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5(4):459\u2013466","journal-title":"Brain Pathol"},{"issue":"4","key":"13_CR149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2990.2007.00868.x","volume":"33","author":"M Jeffrey","year":"2007","unstructured":"Jeffrey M, Gonzalez L (2007) Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathol Appl Neurobiol 33(4):373\u2013394","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"13_CR150","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02952-14","volume":"89","author":"JA Carroll","year":"2015","unstructured":"Carroll JA, Striebel JF et al (2015) Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction. J Virol 89(4):2388\u20132404","journal-title":"J Virol"},{"issue":"4","key":"13_CR151","doi-asserted-by":"crossref","first-page":"e1005551","DOI":"10.1371\/journal.ppat.1005551","volume":"12","author":"JA Carroll","year":"2016","unstructured":"Carroll JA, Striebel JF et al (2016) Prion strain differences in accumulation of PrPSc on neurons and glia are associated with similar expression profiles of neuroinflammatory genes: comparison of three prion strains. PLoS Pathog 12(4):e1005551","journal-title":"PLoS Pathog"},{"issue":"2","key":"13_CR152","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2005.03.008","volume":"20","author":"LM Felton","year":"2005","unstructured":"Felton LM, Cunningham C et al (2005) MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol Dis 20(2):283\u2013295","journal-title":"Neurobiol Dis"},{"issue":"Pt 7","key":"13_CR153","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1099\/vir.0.2008\/001255-0","volume":"89","author":"G Tamguney","year":"2008","unstructured":"Tamguney G, Giles K et al (2008) Genes contributing to prion pathogenesis. J Gen Virol 89(Pt 7):1777\u20131788","journal-title":"J Gen Virol"},{"issue":"19","key":"13_CR154","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1128\/JVI.01340-12","volume":"86","author":"D Tribouillard-Tanvier","year":"2012","unstructured":"Tribouillard-Tanvier D, Race B et al (2012) Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35. J Virol 86(19):10377\u201310383","journal-title":"J Virol"},{"issue":"6563","key":"13_CR155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/379339a0","volume":"379","author":"S Brandner","year":"1996","unstructured":"Brandner S, Isenmann S et al (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379(6563):339\u2013343","journal-title":"Nature"},{"issue":"29","key":"13_CR156","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","volume":"105","author":"MD White","year":"2008","unstructured":"White MD, Farmer M et al (2008) Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A 105(29):10238\u201310243","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5646","key":"13_CR157","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A et al (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302(5646):871\u2013874","journal-title":"Science"},{"issue":"6","key":"13_CR158","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.20093","volume":"55","author":"M Jeffrey","year":"2004","unstructured":"Jeffrey M, Goodsir CM et al (2004) Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann Neurol 55(6):781\u2013792","journal-title":"Ann Neurol"},{"issue":"5727","key":"13_CR159","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M et al (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308(5727):1435\u20131439","journal-title":"Science"},{"issue":"3","key":"13_CR160","doi-asserted-by":"crossref","first-page":"e1000800","DOI":"10.1371\/journal.ppat.1000800","volume":"6","author":"B Chesebro","year":"2010","unstructured":"Chesebro B, Race B et al (2010) Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 6(3):e1000800","journal-title":"PLoS Pathog"},{"issue":"6","key":"13_CR161","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0002-9440(10)64474-4","volume":"161","author":"O Koperek","year":"2002","unstructured":"Koperek O, Kovacs GG et al (2002) Disease-associated prion protein in vessel walls. Am J Pathol 161(6):1979\u20131984","journal-title":"Am J Pathol"},{"issue":"11","key":"13_CR162","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.exphem.2014.06.009","volume":"42","author":"CL Haigh","year":"2014","unstructured":"Haigh CL, Lawson VA et al (2014) Blood vessel cell death during prion disease: implications for disease management and infection control. Exp Hematol 42(11):939\u2013940","journal-title":"Exp Hematol"},{"issue":"5852","key":"13_CR163","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318(5852):930\u2013936","journal-title":"Science"},{"issue":"8","key":"13_CR164","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1371\/journal.ppat.0030125","volume":"3","author":"S Simoneau","year":"2007","unstructured":"Simoneau S, Rezaei H et al (2007) In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 3(8):e125","journal-title":"PLoS Pathog"},{"issue":"8","key":"13_CR165","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1073\/pnas.1118090109","volume":"109","author":"M Zhou","year":"2012","unstructured":"Zhou M, Ottenberg G et al (2012) Highly neurotoxic monomeric alpha-helical prion protein. Proc Natl Acad Sci U S A 109(8):3113\u20133118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 9","key":"13_CR166","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P et al (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129(Pt 9):2278\u20132287","journal-title":"Brain"},{"issue":"4","key":"13_CR167","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","volume":"53","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Ebert E et al (2016) Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob Disease diagnostic. Mol Neurobiol 53(4):2189\u20132199","journal-title":"Mol Neurobiol"},{"issue":"3","key":"13_CR168","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.febslet.2004.12.035","volume":"579","author":"C Soto","year":"2005","unstructured":"Soto C, Anderes L et al (2005) Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 579(3):638\u2013642","journal-title":"FEBS Lett"},{"issue":"8","key":"13_CR169","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nmeth1066","volume":"4","author":"R Atarashi","year":"2007","unstructured":"Atarashi R, Moore RA et al (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4(8):645\u2013650","journal-title":"Nat Methods"},{"issue":"10","key":"13_CR170","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/JVI.74.10.4894-4897.2000","volume":"74","author":"K Doh-Ura","year":"2000","unstructured":"Doh-Ura K, Iwaki T et al (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74(10):4894\u20134897","journal-title":"J Virol"},{"issue":"17","key":"13_CR171","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","volume":"98","author":"C Korth","year":"2001","unstructured":"Korth C, May BC et al (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A 98(17):9836\u20139841","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"13_CR172","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/JVI.67.2.643-650.1993","volume":"67","author":"B Caughey","year":"1993","unstructured":"Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67(2):643\u2013650","journal-title":"J Virol"},{"key":"13_CR173","doi-asserted-by":"crossref","unstructured":"Doh-ura K, Ishikawa K et al (2004) Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78(10):4999\u20135006","DOI":"10.1128\/JVI.78.10.4999-5006.2004"},{"issue":"1\u20132","key":"13_CR174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(97)00152-8","volume":"101","author":"S Perovic","year":"1998","unstructured":"Perovic S, Bohm M et al (1998) Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases. Mech Ageing Dev 101(1\u20132):1\u201319","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"13_CR175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1471-4159.2000.740754.x","volume":"74","author":"A Mange","year":"2000","unstructured":"Mange A, Milhavet O et al (2000) Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies. J Neurochem 74(2):754\u2013762","journal-title":"J Neurochem"},{"issue":"16","key":"13_CR176","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","volume":"99","author":"G Forloni","year":"2002","unstructured":"Forloni G, Iussich S et al (2002) Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 99(16):10849\u201310854","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"13_CR177","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","volume":"300","author":"F Tagliavini","year":"2000","unstructured":"Tagliavini F, Forloni G et al (2000) Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol 300(5):1309\u20131322","journal-title":"J Mol Biol"},{"issue":"5","key":"13_CR178","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","volume":"62","author":"M Otto","year":"2004","unstructured":"Otto M, Cepek L et al (2004) Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 62(5):714\u2013718","journal-title":"Neurology"},{"issue":"23","key":"13_CR179","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","volume":"81","author":"MD Geschwind","year":"2013","unstructured":"Geschwind MD, Kuo AL et al (2013) Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology 81(23):2015\u20132023","journal-title":"Neurology"},{"issue":"5","key":"13_CR180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1468-1331.2008.02108.x","volume":"15","author":"I Bone","year":"2008","unstructured":"Bone I, Belton L et al (2008) Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 15(5):458\u2013464","journal-title":"Eur J Neurol"},{"issue":"5","key":"13_CR181","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1789.2009.01058.x","volume":"29","author":"Y Tsuboi","year":"2009","unstructured":"Tsuboi Y, Doh-Ura K et al (2009) Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 29(5):632\u2013636","journal-title":"Neuropathology"},{"issue":"2","key":"13_CR182","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","volume":"13","author":"S Haik","year":"2014","unstructured":"Haik S, Marcon G et al (2014) Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 13(2):150\u2013158","journal-title":"Lancet Neurol"},{"issue":"3","key":"13_CR183","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000197","volume":"28","author":"MO Kim","year":"2015","unstructured":"Kim MO, Geschwind MD (2015) Clinical update of Jakob-Creutzfeldt disease. Curr Opin Neurol 28(3):302\u2013310","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"13_CR184","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.biocel.2008.05.024","volume":"40","author":"VA Lawson","year":"2008","unstructured":"Lawson VA, Vella LJ et al (2008) Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. Int J Biochem Cell Biol 40(12):2793\u20132801","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"13_CR185","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1128\/JVI.69.12.7754-7758.1995","volume":"69","author":"SA Priola","year":"1995","unstructured":"Priola SA, Chesebro B (1995) A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 69(12):7754\u20137758","journal-title":"J Virol"},{"issue":"23","key":"13_CR186","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1093\/emboj\/20.23.6692","volume":"20","author":"SA Priola","year":"2001","unstructured":"Priola SA, Lawson VA (2001) Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20(23):6692\u20136699","journal-title":"EMBO J"},{"issue":"3","key":"13_CR187","doi-asserted-by":"crossref","first-page":"e89722","DOI":"10.1371\/journal.pone.0089722","volume":"9","author":"JM Torres","year":"2014","unstructured":"Torres JM, Espinosa JC et al (2014) Elements modulating the prion species barrier and its passage consequences. PLoS One 9(3):e89722","journal-title":"PLoS One"},{"issue":"9","key":"13_CR188","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1128\/JVI.02296-14","volume":"89","author":"FK Wiseman","year":"2015","unstructured":"Wiseman FK, Cancellotti E et al (2015) The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species. J Virol 89(9):4738\u20134747","journal-title":"J Virol"},{"issue":"48","key":"13_CR189","doi-asserted-by":"crossref","first-page":"32230","DOI":"10.1074\/jbc.273.48.32230","volume":"273","author":"B Caughey","year":"1998","unstructured":"Caughey B, Raymond GJ et al (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273(48):32230\u201332235","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"13_CR190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S et al (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126(Pt 6):1333\u20131346","journal-title":"Brain"},{"issue":"43","key":"13_CR191","doi-asserted-by":"crossref","first-page":"36465","DOI":"10.1074\/jbc.M112.368803","volume":"287","author":"HM Klemm","year":"2012","unstructured":"Klemm HM, Welton JM et al (2012) The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. J Biol Chem 287(43):36465\u201336472","journal-title":"J Biol Chem"},{"issue":"8","key":"13_CR192","doi-asserted-by":"crossref","first-page":"e1002835","DOI":"10.1371\/journal.ppat.1002835","volume":"8","author":"C Kim","year":"2012","unstructured":"Kim C, Haldiman T et al (2012) Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog 8(8):e1002835","journal-title":"PLoS Pathog"},{"issue":"6602","key":"13_CR193","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge J, Sidle KC et al (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383(6602):685\u2013690","journal-title":"Nature"},{"issue":"1","key":"13_CR194","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/01.wnl.0000167188.65787.a0","volume":"65","author":"V Lewis","year":"2005","unstructured":"Lewis V, Hill AF et al (2005) Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 65(1):113\u2013118","journal-title":"Neurology"},{"issue":"6","key":"13_CR195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39(6):767\u2013778","journal-title":"Ann Neurol"},{"issue":"9433","key":"13_CR196","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","volume":"364","author":"AH Peden","year":"2004","unstructured":"Peden AH, Head MW et al (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364(9433):527\u2013529","journal-title":"Lancet"},{"issue":"2","key":"13_CR197","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/317935","volume":"183","author":"HS Lee","year":"2001","unstructured":"Lee HS, Brown P et al (2001) Increased susceptibility to Kuru of carriers of the PRNP 129 methionine\/methionine genotype. J Infect Dis 183(2):192\u2013196","journal-title":"J Infect Dis"},{"issue":"22","key":"13_CR198","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1073\/pnas.95.22.13239","volume":"95","author":"L Cervenakova","year":"1998","unstructured":"Cervenakova L, Goldfarb LG et al (1998) Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 95(22):13239\u201313241","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR199","doi-asserted-by":"crossref","first-page":"f5675","DOI":"10.1136\/bmj.f5675","volume":"347","author":"ON Gill","year":"2013","unstructured":"Gill ON, Spencer Y et al (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675","journal-title":"BMJ"},{"issue":"3","key":"13_CR200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","volume":"203","author":"DA Hilton","year":"2004","unstructured":"Hilton DA, Ghani AC et al (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203(3):733\u2013739","journal-title":"J Pathol"},{"issue":"7551","key":"13_CR201","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bmj.38804.511644.55","volume":"332","author":"JW Ironside","year":"2006","unstructured":"Ironside JW, Bishop MT et al (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332(7551):1186\u20131188","journal-title":"BMJ"},{"issue":"7557","key":"13_CR202","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature14510","volume":"522","author":"EA Asante","year":"2015","unstructured":"Asante EA, Smidak M et al (2015) A naturally occurring variant of the human prion protein completely prevents prion disease. Nature 522(7557):478\u2013481","journal-title":"Nature"}],"container-title":["Advances in Neurobiology","Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-57193-5_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T11:42:42Z","timestamp":1602416562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-57193-5_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319571911","9783319571935"],"references-count":202,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-57193-5_13","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}